A Massive Study of 250,000 Patients Just Revealed a Surprising New Use for GLP-1s
A new Mayo Clinic analysis of more than 250,000 health records reveals that GLP-1 drugs could outperform metformin in reversing prediabetes and lowering heart risks.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.